immage biotherapeutics corp otcmktsimmg quotes  news  google financecookies help us deliver our services by using our services you agree to our use of cookieslearn moregot itmy accountsearchmapsyoutubeplaynewsgmaildrivecalendargoogletranslatephotosmoreshoppingwalletfinancedocsbooksbloggercontactshangoutskeepeven more from googlesign inhidden fieldssearch financeadobe flash player is required for interactive charts allowfinanceimmage biotherapeutics corpotcmktsimmgadd to portfoliocompanysummarynewsrelated companieshistorical pricesfinancialsmarketsnewsportfoliosstock screenergoogle domestic trendsrecent quotes  daysyou have no recent quoteschg   immage biotherapeutics corp  public otcmktsimmg   watch this stock      jul   close otcmkts data delayed by  mins  disclaimer currency in usd range       week    open      vol  avg  mkt cap m pe      divyield      eps  shares m beta      inst own      news relevance date all news for immage biotherapeutics corp » subscribe advertisement key stats and ratios q feb   net profit margin   operating margin   ebitd margin   return on average assets   return on average equity   cdp score   more ratios from thomson reuters » address  motor city dr ste bethesda md united states  map phone website links httpwwwimmagebiocom settings  technicals  link to this view sources include six advertisement related companies show most recent quarter most recent annual add or remove columns save changes cancel more from factset » description immage biotherapeutics corp is a biotechnology company the company develops cancer immunotherapy through development of immunotherapy candidates using bioinformatics and outsourced laboratory resources the company develops markets and licenses its immunotherapy candidate for melanomaassociated antigena mage a the company plans to focus on the development of immunotherapy for breast and prostate cancer the company focuses on developing a fusionhybrid antigen cancer vaccine that would not only be human leukocyte antigen hla free but also be effective to all the isomers associated with mage a from  to  and the identification and development of immunotherapy candidates from its intellectual property library for the preparation for human clinical trials using a viral vector construct as of may   the company had not generated any revenues more from reuters » officers and directors anton dormer md chairman of the board chief scientific officer zhi cong mou president chief executive officer treasurer secretary director age  elton f norman chief financial officer director mahesh narayanan chief operating officer director daniel achinko vice president  bioformatics full list on reuters » google finance beta available in hong kong  canada  us  china  ukinformation is provided as is and solely for informational purposes not for trading purposes or advice and may be delayedto see all exchange delays please see disclaimer google  google home  blog  help  report a problem  privacy policy  terms of service immage biotherapeutics  leveraging the power of the immune system leverage the power of the immune system creating a new image of cancer therapeutics immage biotherapeutics corp develops targeted therapeutics for the treatment of tumors that expresses the magea antigen this growing portfolio of treatment targets using one universal vaccine gives the company the advantage of focusing on tumors that have not had viable treatments and yet reduces cost as it is one therapy our pipeline is built from a proprietary immunotherapy that can be use alone and in strategic combinations in order to development novel diseasespecific therapies that enhance the bodys immune response to treat cancers immage biotherapeutics  leveraging the power of the immune system leverage the power of the immune system about us immage biotherapeutics corp otc immg has been founded on the foundational understanding that many cancers can be treated via the harnessing the power of the human immune system the pipeline of the company consists of a dna viral vaccine construct that is target to tumors that expresses the melanoma antigen family – a magea antigen the company has a pipeline of therapeutics that has a high success probability because our treatment targets patient population medical needs are not being met at this time our leading pipeline is a universal vaccine that can be used for any tumor that expresses tumor antigen magea this treatment can be targeted to cancers that has a high expression of the magea antigen including breast colon pancreas glioblastoma and esophageal squamous cell carcinomas for example the company expects to focus on developing the treatment for triple negative breast cancer our research that will be ongoing is designed to reach human clinical trials and market via the leveraging of the immune system with its ability to treat tumors the key to our strategies also includes our ability to combine our technology with antipdl andor antictl with the potential for positive results of the ongoing preclinical stage programs the next stage would allow the company to viable biotechnology commercial entity learn more about magea the magea antigen is a cancer testis antigen that is expressed within the human testes it is highly immunogenic and has been considered as a viable target for the development of immunotherapies of tumors overexpressing the magea family of antigens the magea subfamily of cancer testis antigen are expressed in germ cells though not exclusively they may drive malignancy and since those antigens are highly immunogenic they lend themselves to possibly becoming potential effective target for immunotherapies antigens particular to each magea family has a unique expression pattern and related tissue target which defines its differential use as immunotherapy regiments zhi cong mou – an industry veteran for start ups with vital experience in spearheading and managing numerous small start up companies mr mou is widely knowledgeable about the numerous teething problems that start ups often face and how to manage them his experience makes him an invaluable person to have on a company’s board and he is currently focused on leading the team and ensuring that immage biotherapeutics continues to grow from strength to strength mahesh narayanan  biotechnology entrepreneur with extensive experience in the healthcare and life sciences industry he has a masters in biotechnology from university of pennsylvania with experience in business development consulting for startups as well as research in academia and pharmaceutical industry focusing on antibiotics and vaccines anton dormer  dr anton dormer is a former associate professor at washington adventist university located in takoma park md he received a medical doctorate from utesa and a masters in biotechnology and biomedical sciences from university of massachusetts boston dr dormers research focus is the development of peptide vaccine for the prevention of treatment of makor human pathologies and cancers elton norman  elton f norman graduated cum laude from howard university school of law in  he served as a member of the howard law review he earned a bba in accounting from andrews university in  mr norman has extensive experience in financial statements preparation and review and the formation counseling and governance of business entities mr normans work experience includes securities offerings public and private debt and equity offerings public company sec compliance mergers and acquisitions venture capital financing forprofit and nonprofit corporate formations and corporate counseling mr norman also has significant experience working with small and startup businesses mr norman worked for approximately ten  years as a corporatesecurities attorney for major law firms before founding the norman law firm pllc where he is currently the managing member daniel achinko  dr daniel achinko is a research scientist with a doctorate in bioinformatics from university of yaounde i uyi with a focus on coparasitic infections and a masters in molecular parasitology with a focus on genotyping the plasmodium strains of malaria he is currently a member of the east african bioinformatics group and the international society of computational biology dr achinko is leading the efforts for in vitro trials and protocol design at immage immage therapeutics is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel diseasespecific therapies that induce enhance or suppress the bodys immune response microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft immage biotherapeutics corp  motor city dr bethesda md biotechnology products  services  mapquest immage biotherapeutics corp  motor city dr bethesda md  reviews website menu  reservations make reservations order online tickets tickets see availability nearby directions  date name shares transaction value  mahesh narayanan     newslatestcompanyusimmg marketwatch news on immg no news currently available for immg newsnonmarketwatchcompanyusimmg other news on immg q immage biotherapeutics corp  pm april    edgar online  edg  q k immage biotherapeutics a sleeping giant awakens from its slumber  pm feb    seeking alpha q immage biotherapeutics corp  pm jan    edgar online  edg  q k k immage biotherapeutics corp  pm dec    edgar online  edg  q k at a glance immage biotherapeutics corp  motor city drive suite  bethesda maryland  phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue na net income  employees  annual report for immg newspressreleasecompanyusimmg press releases on immg immage biotherapeutics comments on the filing of form   am july    pr newswire  prf immage biotherapeutics begins repeat toxicology study for lead candidate  am may    pr newswire  prf immage biotherapeutics dna immunotherapy shows high efficacy with low toxicology results  pm march    pr newswire  prf immage biotherapeutics closes out  in france as a yei laureate  pm feb    pr newswire  prf immage biotherapeutics announces positive results from animal studies  am nov    pr newswire  prf new milestones and recognition for immage biotherapeutics  am sept    pr newswire  prf trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  immgotc us stock quote  immage biotherapeutics corp  bloomberg markets error could not add to watchlist x  watchlist immage biotherapeutics corp immgus otc us usd   as of  pm edt  open  day range    volume  previous close  wk range    before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range    ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later  immage biotherapeutics comments on the filing of form   immage biotherapeutics begins repeat toxicology study for lead candidate  immage biotherapeutics dna immunotherapy shows high efficacy with low toxicology results  immage biotherapeutics closes out  in france as a yei laureate there are currently no press releases for this ticker please check back later profile immage biotherapeutics corp is an early stage biotechnology company the company develops cancer immunotherapies including vaccines oncolytic viruses adjuvants and adoptive tcell technologies address  motor city drivesuite bethesda md united states phone  website  executives board members anton dormer chairmanchief scientific officer mou zhi cong presidentceotreasurer elton norman chief financial officer mahesh narayanan chief operating officer daniel achinko vpbioformatics show more epcc stock quote  immage biotherapeutics corp  bloomberg markets error could not add to watchlist x  watchlist immage biotherapeutics corp epccus ticker change epccus has changed to a new ticker symbol usd volume  before its here its on the bloomberg terminal learn more volume  current pe ratio ttm  earnings per share usd ttm  market cap usd  shares outstanding  pricesales ttm  dividend indicated gross yield  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later there are currently no press releases for this ticker please check back later profile immage biotherapeutics corp is an early stage biotechnology company the company develops cancer immunotherapies including vaccines oncolytic viruses adjuvants and adoptive tcell technologies address  motor city drivesuite bethesda md united states phone  website  executives board members anton dormer chairmanchief scientific officer mou zhi cong presidentceotreasurer elton norman chief financial officer mahesh narayanan chief operating officer daniel achinko vpbioformatics show more ti ticky  find out what the market really thinks p about usour productstraders areasupporttrainingmy account navigation home about us our products traders area support training my account trade ideas finds your next trade in immage biotherapeutics corp common new stock look up thursday julam immg immage biotherapeutics corp common company info exchangepinksectormanufacturingsub sectorchemical manufacturingindustry grouppharmaceutical and medicine manufacturingsub industrybiological product except diagnostic manufacturing price actionlast price  at the closeimmg is down  since the beginning of the yearimmg is down  below  day smaimmg is down na below  day sma volume action x current relative volume total volume today is  shares  total volume k  avg k  vol last  min  shares financialsprofitable noeps earnings momentum nana increase in qtrly earningspe ratio is naincome to debt ratio revenue is nadebt is cash is k what does the market think   poor the stock is  away from alltime highs of  immg is down  since the beginning of the year immg is down  over the past  months immg is down  over the past  month na of all immg investors are betting against immg num investors short immg has gone up na versus last month newest alertstypedescriptiontime momentum immg moved up  in the previous minute immg is up  over the last hour immg is up  over the last  days immg is  above its  day sma where is immg  day   previous day   week   month   year  immg social trends  immg is mentioned na less than normal on  immg is mentioned  times in an average day on make your trading predictably profitable   activate your account why are we different what is trade ideas follow us on twitter tweets from tradeideasscottradeideas         follow tradeideas tradeideas disclosure statement privacy statement contact us site map mobile browsing  copyright  trade ideas llc all rights reserved